30 julio 2012

"Pharma Mar, S.A. - Product Pipeline Review - 2012" . 500 $ el Informe .

30.07.2012 19:25:41 - Fast Market Research recommends "Pharma Mar, S.A. - Product Pipeline Review - 2012" from Global Markets Direct, now available .

(live-PR.com) - Global Market Direct's pharmaceuticals report, "Pharma Mar, S.A. - Product Pipeline Review - 2012" provides data on the Pharma Mar, S.A.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Pharma Mar,

S.A.'s corporate website, SEC filings, investor presentations and featured press releases, both from Pharma Mar, S.A. and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

* Pharma Mar, S.A. - Brief Pharma Mar, S.A. overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of Pharma Mar, S.A. human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Pharma Mar, S.A. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Pharma Mar, S.A.'s pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.

...